AstraZeneca | Results Presentation Deck

Slide schematic 4/4

source-note 1/1 table 1/1 title 2/2

Components 4

source-note data headline subtitle

Tools 1

table/data: Trial, Population, Patients, Design, Endpoints, Status. Phase I NCT06122714, Healthy volunteers, 96, Randomised, single-blind, placebo-controlled, SAD/MAD sequential group trial, Primary endpoints: safety and

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

The slide uses a standard clinical trial registry format.